These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27573929)

  • 1. Role of Salmonella Typhi Vi Antigen and Secretory Systems on Immune Response.
    Schadich E; Dzubak P; Hajduch M
    Curr Pharm Des; 2016; 22(41):6251-6260. PubMed ID: 27573929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
    Haque A
    Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Virulence Polysaccharide of
    Parween F; Yadav J; Qadri A
    Front Cell Infect Microbiol; 2019; 9():141. PubMed ID: 31134159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X; Chen Z; Xiong K; Wang J; Rao X; Cong Y
    Crit Rev Microbiol; 2017 Aug; 43(4):440-452. PubMed ID: 27869515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.
    Santander J; Wanda SY; Nickerson CA; Curtiss R
    Infect Immun; 2007 Mar; 75(3):1382-92. PubMed ID: 17178790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter.
    Janis C; Grant AJ; McKinley TJ; Morgan FJ; John VF; Houghton J; Kingsley RA; Dougan G; Mastroeni P
    Infect Immun; 2011 Jun; 79(6):2481-8. PubMed ID: 21402763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of Vi gene, its expression and Salmonella Pathogenicity Island (SPI-7) in Salmonella Typhi in India.
    Maurya P; Gulati AK; Nath G
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):913-9. PubMed ID: 21073066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of active component US military personnel against Salmonella Typhi.
    Porter CK; Sorrell T; Mitra I; Riddle MS
    Vaccine; 2017 Mar; 35(14):1742-1748. PubMed ID: 28268075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conjugate vaccines against bacterial infections: typhoid fever].
    Paniagua J; García JA; López CR; González CR; Isibasi A; Kumate J
    Salud Publica Mex; 1992; 34(3):268-73. PubMed ID: 1377407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
    Das S; Chowdhury R; Ghosh S; Das S
    Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.
    Ferry BL; Misbah SA; Stephens P; Sherrell Z; Lythgoe H; Bateman E; Banner C; Jones J; Groome N; Chapel HM
    Clin Exp Immunol; 2004 May; 136(2):297-303. PubMed ID: 15086394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin transforms anti-inflammatory Salmonella typhi virulence polysaccharide into a TLR-2 agonist.
    Garg R; Qadri A
    J Immunol; 2010 Jun; 184(11):5980-7. PubMed ID: 20439919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.
    Kirkpatrick BD; McKenzie R; O'Neill JP; Larsson CJ; Bourgeois AL; Shimko J; Bentley M; Makin J; Chatfield S; Hindle Z; Fidler C; Robinson BE; Ventrone CH; Bansal N; Carpenter CM; Kutzko D; Hamlet S; LaPointe C; Taylor DN
    Vaccine; 2006 Jan; 24(2):116-23. PubMed ID: 16140433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.